Rapport Therapeutics Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$45.49

-0.86 (-1.86%)

As of Aug 8, 10:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target -0.7% upside

Low Target $32.24

Average Target $45.18

High Target $61.72

Current Price $45.49

Current
$45.49

Target
$45.18

$32.24 $45.18 avg $61.72

Scenario Analysis

Bear Case

$32.24

-29.1%

Low target

Base Case

$45.18

-0.7%

Avg target

Bull Case

$61.72

+35.7%

High target

Risk/Reward

1.2x

Balanced

Price in Context

52-Week High

$46.72

-2.6% from high

52-Week Low

$13.62

+234.0% from low

Target vs 52W High

$45.18

-3.3% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%